# Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

> **NCT07248956** · PHASE2 · RECRUITING · sponsor: **Eye & ENT Hospital of Fudan University** · enrollment: 116 (estimated)

## Conditions studied

- Hypopharyngeal Carcinoma

## Interventions

- **DRUG:** Finolizumab
- **DRUG:** Albumin-Bound Paclitaxel /nab-Paclitaxel
- **DRUG:** Cisplatin
- **RADIATION:** Definitive radiotherapy
- **PROCEDURE:** Surgery with postoperative radiotherapy or chemoradiotherapy.

## Key facts

- **NCT ID:** NCT07248956
- **Lead sponsor:** Eye & ENT Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-22
- **Primary completion:** 2027-11-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07248956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07248956, "Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07248956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*